It has been observed that the imbalance between pro-proliferative BCL2 and pro-apoptotic BAX expression, which leads to a high BCL2/BAX ratio in CLL cells, rather than expression levels of the individual proteins, is associated with improved survival and progression of the disease. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.